Dr. Katsushige Gomi

Scientific Director, Pharmaceutical
Dr. Katsushige Gomi, Scientific Director, Pharmaceutical

Major projects

  • Clinical development and medical affairs of irinotecan and oxaliplatin
  • Clinical development of istradefylline
  • Preclinical studies and medical affairs of 5-fluorouracil, mitomycin C, adriamycin, farmorubicin, vinorelbine, medroxyprogesterone and G-CSF


  • Since 2017 Scientific Director, Takanawa Pharma
  • 2014 – 2016 Senior Officer, Nichi-Iko
  • 2013 – 2014 Director, Global Study Clinical Research Department, CMIC
  • 2005 – 2013 Deputy General Manager, Yakult
  • 1975 – 2005 General Manager, Deputy GM, Managing Researcher and Researcher, Kyowa Hakko


  • Ph.D. in Pharma Science, Tokyo University
  • B.Sc. in Pharma Science, Tokyo University
  • Visiting scientist at Japanese Foundation for Cancer Research
  • Visiting scientist at National Cancer Institute, Bethesda, USA

Civic Engagement

  • Member of ASCO and AACR
  • Member of JSMO (Japanese equivalent of ASCO)